COLORADO DENVER UNIVERSITY OF

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-1 - 4

Phase 2

Withdrawn

Conditions: Opioid-Related Disorders
Heroin Dependence

First Posted Date: 1999-09-21

Last Posted Date: 2017-05-04

Lead Sponsor: University of Colorado, Denver

Registration Number: NCT00000329

Locations: 🇺🇸
University of Colorado Health Sciences Center, Denver, Colorado, United States

Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment III) - 3

Phase 2

Withdrawn

Conditions: Heroin Dependence
Opioid-Related Disorders

First Posted Date: 1999-09-21

Last Posted Date: 2017-05-04

Lead Sponsor: University of Colorado, Denver

Registration Number: NCT00000328

Locations: 🇺🇸
University of Colorado Health Sciences Center, Denver, Colorado, United States

Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-2 - 5

Phase 2

Withdrawn

Conditions: Opioid-Related Disorders
Heroin Dependence

First Posted Date: 1999-09-21

Last Posted Date: 2017-05-04

Lead Sponsor: University of Colorado, Denver

Registration Number: NCT00000330

Locations: 🇺🇸
University of Colorado Health Sciences Center, Denver, Colorado, United States

Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-3 - 6

Phase 2

Withdrawn

Conditions: Heroin Dependence
Opioid-Related Disorders

Interventions: Drug: Placebo Drug
Drug: Test Drug

First Posted Date: 1999-09-21

Last Posted Date: 2017-05-04

Lead Sponsor: University of Colorado, Denver

Registration Number: NCT00000331

Locations: 🇺🇸
University of Colorado Health Sciences Center, Denver, Colorado, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy